ERD

Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-s...

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patient...

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced N...

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell respo...

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Cross-talk between iNKT cells and CD8 T cells in the spleen requires the IL-4/CCL17 axis for the generation of short-liv...

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy.

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Pazopanib induces dramatic but transient contraction of myeloid suppression compartment in favor of adaptive immunity

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Is impaired response to PD-1 blockers of high serum PD-1 patients related to immune complexes?

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

BMCMDA: a novel model for predicting human microbe-disease associations via binary matrix completion

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Microfluidics-Assisted Size Tuning and Biological Evaluation of PLGA Particles

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS)—Mediated Anti-tumor Therapy

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

DIPEPTIDE PIPERIDINE DERIVATIVES

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

ARGINASE INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Enhanced Antitumor Efficacy through an “AND gate” Reactive Oxygen-Species-Dependent pH-Responsive Nanomedicine Appro...

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

A novel computational method for automatic segmentation, quantification and comparative analysis of immunohistochemicall...

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-...

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

A comparative assessment of continuous production techniques to generate sub-micron size PLGA particles

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Forster Resonance Energy Transfer-Based Stability Assessment of PLGA Nanoparticles in Vitro and in Vivo

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Industrial Scale Manufacturing and Downstream Processing of PLGA-Based Nanomedicines Suitable for Fully Continuous Opera...

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in re...

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Internal Structure of Thermoresponsive Physically Crosslinked Nanogel of Poly[N-(2-hydroxypropyl)methacrylamide]-Block-P...

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

The STEAP1 262-270 peptide encapsulated into PLGA microspheres elicits strong cytotoxic T cell immunity in HLA-A*0201 tr...

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer...

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Assessment of anti-PD-1 antibody and immune complex binding to Fc gamma receptors and clinical implications

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

The AURORA of a New Way to Value Myeloid Immunosuppression in Cancer

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Translating the Manufacture of Immunotherapeutic PLGA Nanoparticles from Lab to Industrial Scale: Process Transfer and I...

Project: PRECIOUS

Updated at: 29-04-2024

Show more information

Project acronym PRECIOUS

Resources

Selected filters:

Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-s...

Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patient...

Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced N...

Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell respo...

Cross-talk between iNKT cells and CD8 T cells in the spleen requires the IL-4/CCL17 axis for the generation of short-liv...

microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy.

Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy

PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up

Pazopanib induces dramatic but transient contraction of myeloid suppression compartment in favor of adaptive immunity

Is impaired response to PD-1 blockers of high serum PD-1 patients related to immune complexes?

BMCMDA: a novel model for predicting human microbe-disease associations via binary matrix completion

Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma

Microfluidics-Assisted Size Tuning and Biological Evaluation of PLGA Particles

Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS)—Mediated Anti-tumor Therapy

DIPEPTIDE PIPERIDINE DERIVATIVES

ARGINASE INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS

PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses

Enhanced Antitumor Efficacy through an “AND gate” Reactive Oxygen-Species-Dependent pH-Responsive Nanomedicine Appro...

A novel computational method for automatic segmentation, quantification and comparative analysis of immunohistochemicall...

PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-...

A comparative assessment of continuous production techniques to generate sub-micron size PLGA particles

Forster Resonance Energy Transfer-Based Stability Assessment of PLGA Nanoparticles in Vitro and in Vivo

Industrial Scale Manufacturing and Downstream Processing of PLGA-Based Nanomedicines Suitable for Fully Continuous Opera...

Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in re...

Internal Structure of Thermoresponsive Physically Crosslinked Nanogel of Poly[N-(2-hydroxypropyl)methacrylamide]-Block-P...

The STEAP1 262-270 peptide encapsulated into PLGA microspheres elicits strong cytotoxic T cell immunity in HLA-A*0201 tr...

Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer...

Assessment of anti-PD-1 antibody and immune complex binding to Fc gamma receptors and clinical implications

The AURORA of a New Way to Value Myeloid Immunosuppression in Cancer

Translating the Manufacture of Immunotherapeutic PLGA Nanoparticles from Lab to Industrial Scale: Process Transfer and I...